Cumberland Pharmaceuticals (CPIX) Reports Q3 EPS of $0.04

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.04, versus $0.10 reported last year. Revenue for the quarter came in at $7.9 million, versus $9.73 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Green Dot and CommerceOne shareholders approve acquisition deal
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters